Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.
Christiane Dolecek, Sadia Shakoor, Buddha Basnyat and 2 more
PLoS Biology · 2022
doi:10.1371/journal.pbio.3001903 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Despite high mortality and morbidity, drug-resistant bacterial infections remain the forgotten pandemic. We argue for strengthening of diagnostics, WASH (water, sanitation, and hygiene) and infection prevention and control to reduce drug-resistant infections, as an integral part of sustainable high-quality health services, particularly in low- and middle-income countries.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.